Skip to Content

Markets
Technicals
Companies
Earnings
Close-Up
Themes

News

Market and company headlines

Loading

A personal project for following the US markets. Free, ad-free and open source.

Weekly Recap

Every Sunday morning: the week's earnings behind you and the calendar ahead, in one email.

Get It by Email

Market

Markets
Companies
Stock Screener
Macro
Earnings
Technical Analysis
Calendar
Compare
Thematic Lists
Famous Investors

Reading

Guide
Close-Up
Community
News
Brief Archive
Glossary
Tax Calculator
RSS

Account

Watchlist
My Posts
Bell Report
Portfolio
Settings
Privacy

© 2026 Opening BellPrivacy About What's New ContactNot Investment AdviceAhmet Akyapı

Markets Earnings Close-Up Menu

Nasdaq 100 · QQQ721.68+ 1.33%S&P 500 · SPY770.01+ 0.61%Dow Jones · DIA523.32+ 0.07%Russell 2000 · IWM280.14+ 1.14%

Bristol Myers falls 3% despite positive cancer drug trial results
Bristol-Myers Squibb Co (NYSE:BMY, XETRA:RM, OTC:BMYMP) shares fell 3% to $57.39 after positive results from a late-stage trial of an experimental cancer treatment raised questions about the market’s reaction to the announcement. The US drugmaker reported that its ACTION-1 Phase 3 trial met...
Yahoo13:0515 Days AgoRM+1.1%

07:00Oct 81 Story

Regional Management: A 3.7% Yield, But The Cheap Debt Is Running Out
Regional Management is a branch installment lender with 357 storefronts trading at 0.81x book. Read why RM stock is a hold.
SeekingAlpha07:29RM+1.1%